What is LOPJLB’s current signal on DYAI?

LOPJLB’s latest quantitative signal on Dyadic International, Inc. (DYAI) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is DYAI in?

Dyadic International, Inc. (DYAI) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Dyadic International, Inc. (DYAI) do?

Dyadic International, Inc. operates as a U.S.-based biotechnology platform company, specializing in the development, production, and commercialization of enzymes and other proteins. Its core activities are underpinned by a patented and proprietary C1 platform, alongside other advanced technologies. This technological foundation drives their research, development, and commercial endeavors, focus…

Dyadic International, Inc. (DYAI)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.41-4.65%Close

SELLCRISIS · day 3

Company news

defenseworld.net · 10d ago

Dyadic International Targets Commercial Traction as Life Sciences Products Launch

defenseworld.net · 11d ago

Dyadic International (NASDAQ:DYAI) & Amylyx Pharmaceuticals (NASDAQ:AMLX) Critical Review

defenseworld.net · 15d ago

Dyadic International (NASDAQ:DYAI) Stock Breaks Below 50-Day Moving Average – Here’s Why

seekingalpha.com · 30d ago

Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

defenseworld.net · 30d ago

Dyadic International (NASDAQ:DYAI) Stock Passes Below 50-Day Moving Average – Time to Sell?

globenewswire.com · 63d ago

Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement

seekingalpha.com · 63d ago

Dyadic International, Inc. (DYAI) Q2 2026 Earnings Call Transcript

globenewswire.com · 64d ago

Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas

defenseworld.net · 65d ago

Reviewing Dyadic International (NASDAQ:DYAI) and Myriad Genetics (NASDAQ:MYGN)

globenewswire.com · 72d ago

Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement

globenewswire.com · 73d ago

Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026

globenewswire.com · 79d ago

Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days

globenewswire.com · 83d ago

Dyadic Announces Continued Listing on the Nasdaq Capital Market

globenewswire.com · 91d ago

Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program

Market news & ticker search · RSS for DYAI

FAQ

What is LOPJLB’s current signal on DYAI?: LOPJLB’s latest quantitative signal on Dyadic International, Inc. (DYAI) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is DYAI in?: Dyadic International, Inc. (DYAI) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does Dyadic International, Inc. (DYAI) do?: Dyadic International, Inc. operates as a U.S.-based biotechnology platform company, specializing in the development, production, and commercialization of enzymes and other proteins. Its core activities are underpinned by a patented and proprietary C1 platform, alongside other advanced technologies. This technological foundation drives their research, development, and commercial endeavors, focus…

Dyadic International, Inc. (DYAI)

Key stats

Prediction markets

Company news

FAQ